BriaCell Therapeutics Corp. 10-Q filing
Filed 2026-03-10 · Report date 2026-01-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-009557
- Form type
- 10-Q
- CIK
- 0001610820
- Primary document
- https://www.sec.gov/Archives/edgar/data/1610820/000149315226009557/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BriaCell Therapeutics Corp..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-15.9M | - | - |
| Net Income | $-15.4M | - | - |
| Eps Basic | -2.58 | - | - |
| Eps Diluted | -6.58 | - | - |
| Cash And Equivalents | $29.9M | - | - |
| Total Assets | $33.6M | - | - |
| Operating Cash Flow | $-15.7M | - | - |